Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Dermatology ; 220(2): 147-53, 2010.
Article in English | MEDLINE | ID: mdl-20029163

ABSTRACT

BACKGROUND: To the best of our knowledge, only 52 cases of squamous cell carcinoma (SCC) complicating hidradenitis suppurativa (HS) have been reported since 1958. We describe 13 new cases. METHODS: We propose a clinical and histological analysis of our cases. We include these results in a review of previously reported cases to analyze a total of 65 patients. In our series of 13 cases, we also investigate the presence of human papillomavirus (HPV) in tumor samples, by polymerase chain reaction (PCR) on paraffin-embedded material. RESULTS: Malignant transformation affects mainly men with a long-term history of genitoanal HS. Although our cases were 7 well-differentiated carcinomas and 6 verrucous carcinomas, lymphatic and visceral metastasis occurred in 2 and 3 cases, respectively. With PCR, we demonstrated presence of HPV in genitoanal tumoral lesions, principally HPV-16. CONCLUSION: SCC complicating HS evolves poorly, despite a good histological prognosis. Our results sustain the implication of HPV in the malignant transformation of HS.


Subject(s)
Anus Neoplasms/pathology , Carcinoma, Squamous Cell/pathology , Hidradenitis Suppurativa/pathology , Human papillomavirus 16 , Papillomavirus Infections/pathology , Urogenital Neoplasms/pathology , Adolescent , Adult , Anus Neoplasms/complications , Anus Neoplasms/virology , Carcinoma, Squamous Cell/complications , Carcinoma, Squamous Cell/virology , Carcinoma, Verrucous/complications , Carcinoma, Verrucous/pathology , Carcinoma, Verrucous/virology , Cell Transformation, Neoplastic/pathology , Female , Hidradenitis Suppurativa/complications , Hidradenitis Suppurativa/virology , Humans , Male , Papillomavirus Infections/complications , Retrospective Studies , Smoking/adverse effects , Urogenital Neoplasms/complications , Urogenital Neoplasms/virology , Young Adult
2.
Ann Dermatol Venereol ; 136(11): 767-71, 2009 Nov.
Article in French | MEDLINE | ID: mdl-19917428

ABSTRACT

BACKGROUND: There is no international consensus on practical methods of monitoring melanoma following surgical removal of a primary tumour. The chief aim of such monitoring is to ensure detection of relapse where early diagnosis is crucial for survival (i.e. in-transit and lymph node metastases amenable to surgical removal) and the emergence of any first recurrence of primary melanoma. AIM: The aim of our study was to identify the role of various agents and diagnostic tools both in first recurrence of primary melanoma and in clinical relapse of melanoma. PATIENTS AND METHODS: This was a retrospective study covering all patients with in-transit or regional lymph node metastasis seen between January 2005 and December 2007. The type of recurrence and method of detection were studied. RESULTS: Ninety-four patients presented recurrence, with 66% of relapses comprising regional lymph node metastasis and 34% consisting of in-transit metastases. Thirty-three percent of cases of recurrence were detected by patients themselves, 21% by our department, 22% by a private dermatologist, 18% by a radiologist and 6% by a general practitioner. Fifty-four percent of recurrences among patients aged under 50 years were self-detected compared to 18% among patients aged over 70 years. A second melanoma was detected in six patients. DISCUSSION: This study underscores the great importance of self-examination in melanoma follow-up with over one third of recurrences being self-detected by patients. Self-examination was more effective for younger patients, emphasizing the need to increase awareness among older patients. This study also demonstrates the essential part played by dermatologists in terms of regular follow-up of melanoma.


Subject(s)
Melanoma/epidemiology , Neoplasm Recurrence, Local/epidemiology , Neoplasms, Second Primary/epidemiology , Skin Neoplasms/epidemiology , Axilla/pathology , Female , Humans , Inguinal Canal/pathology , Melanoma/pathology , Melanoma/surgery , Neoplasm Recurrence, Local/pathology , Neoplasms, Second Primary/pathology , Retrospective Studies , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Uterine Cervical Neoplasms/pathology
3.
Photodermatol Photoimmunol Photomed ; 22(3): 153-6, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16719870

ABSTRACT

BACKGROUND: Erythrasma is a superficial cutaneous infection caused by Corynebacterium minutissimum and is characterized by fluorescence under Wood's light (UV) because of the presence of porphyrins. These molecules are photosensitizing and we propose to assess efficacy of red light that activates porphyrins (photodynamic reaction) in treatment of this pathology. OBJECTIVES: Assessment of effects of photodynamic action of red light for treatment of erythrasma without exogenous photosensitizing molecules. METHODS: Thirteen patients with erythrasma were treated by one illumination (80 J/cm2) by red light (broad band, peak at 635 nm) without exogenous photosensitizing molecules. Disappearance or reduction of extent of lesions were observed 2 weeks later. If lesions were still present, a second irradiation was conducted with the same method. RESULTS: Preliminary results are presented. As a result of red light irradiation, we noticed a complete recovery for three patients and, in most other cases, reduction of extent of lesions (mean: -29% after one session). The treatment was well tolerated. CONCLUSION: We report first cases of photodynamic treatment of erythrasma. There are other reports of clinical applications of antimicrobial action of photodynamic therapy in dermatology (acne vulgaris, leishmaniasis, warts, etc.). But there are few applications without addition of exogenous photosensitizing agent. The originality and interest of our study is to use spontaneous presence of porphyrins in the lesions. This technique seems to be an interesting alternative, inexpensive and easy, for the treatment of this localized infection. But an optimal method is still to be determined to improve efficacy.


Subject(s)
Erythrasma/drug therapy , Photochemotherapy , Photosensitizing Agents/pharmacology , Adult , Aged , Female , Humans , Male , Middle Aged , Photochemotherapy/methods , Prospective Studies , Remission Induction , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...